Outcomes similar for therapy-related, de novo MDS after haplo-HSCT
Patients with therapy-related myelodysplastic syndrome (t-MDS) and de novo MDS have comparable outcomes after haploidentical hematopoietic stem cell transplantation (haplo-HSCT), according to a study published online Feb. ...
Feb 21, 2024
0
0